FIB-4 Index Is Associated with Hepatocellular Carcinoma Risk in HIV-Infected Patients
Open Access
- 1 December 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 20 (12) , 2512-2517
Abstract
Background: Chronic inflammation caused by hepatitis B virus infection, hepatitis C virus infection, and/or heavy alcohol use can lead to fibrosis, cirrhosis, and eventually hepatocellular carcinoma (HCC). FIB-4 is an index score calculated from platelet count, alanine transaminase, aspartate transaminase, and age that predicts fibrosis and cirrhosis. We hypothesized that high FIB-4 would be associated with development of HCC in HIV-infected persons, who are at high risk due to high prevalence of viral hepatitis and alcohol consumption, and possibly due to HIV infection itself. Methods: Using proportional hazards models, we tested this hypothesis among 22,980 HIV-infected men from the Veterans Aging Cohort Study. We identified incident HCC cases from the Veterans Affairs Central Cancer Registry. Results: During follow-up, there were 112 incident HCC diagnoses. The age- and race/ethnic group-adjusted HR was 4.2 [95% confidence interval (CI), 2.4–7.4] for intermediate FIB-4 and 13.0 (95% CI, 7.2–23.4) for high FIB-4, compared with low FIB-4. After further adjustment for enrollment year, CD4 count, HIV-1 RNA level, antiretroviral therapy use, hepatitis B and C virus infection, alcohol abuse/dependency, and diabetes, FIB-4 remained a strong, significant, independent risk factor for HCC. The multivariate-adjusted HR was 3.6 (95% CI, 2.1–6.4) for intermediate FIB-4 and 9.6 (95% CI, 5.2–17.4) for high FIB-4. Conclusions: Calculated from routine, noninvasive laboratory tests, FIB-4 is a strong, independent HCC risk factor in HIV-infected patients. Impact: FIB-4 might prove valuable as an easily measured index to identify those at highest risk for HCC, even prior to development of clinical cirrhosis. Cancer Epidemiol Biomarkers Prev; 20(12); 2512–7. ©2011 AACR.Keywords
This publication has 21 references indexed in Scilit:
- A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)BMC Gastroenterology, 2011
- HIV infection and the risk of diabetes mellitusAIDS, 2009
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinomaAnnals of Oncology, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Development and Verification of a “Virtual” Cohort Using the National VA Health Information SystemMedical Care, 2006
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Epidemiology of viral hepatitis and HIV co-infectionJournal of Hepatology, 2006
- Screening for hepatocellular carcinomaDigestive and Liver Disease, 2005
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003